Biotech · Private company
Telavant, Inc.
Track this companyFree. Adds Telavant, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- PF-06480605Phase 2 · Colitis, UlcerativeClinicalTrials.gov · fetched Nov 12, 2026
- PF-06480605Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.PHASE2 · COMPLETED · started Oct 26, 2016ClinicalTrials.gov NCT02840721 · fetched Nov 12, 2026
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects.PHASE1 · COMPLETED · started Dec 1, 2013ClinicalTrials.gov NCT01989143 · fetched Nov 12, 2026